Tousif Pasha, Jenny Heathcote, Sherine Gabriel, Karen Cauch‐Dudek, Roberta Jorgensen, Terry Therneau, E. Rolland Dickson, Keith D. Lindor – 30 December 2003 – Ursodeoxycholic acid (UDCA) is a safe and effective treatment for patients with primary biliary cirrhosis (PBC), but the cost of this drug has raised concerns regarding cost‐effectiveness. The aim of our study was to determine the cost‐effectiveness of UDCA in PBC. We compared the costs and outcomes of managing PBC patients with and without UDCA.

James Neuberger, Richard Thomson – 30 December 2003

Montserrat Jaumot, Josep‐Maria Estanyol, Joan Serratosa, Neus Agell, Oriol Bachs – 30 December 2003 – Partial hepatectomy (PH) triggers the entry of rat liver cells into the cell cycle. The signals leading to cell‐cycle activation converge into a family of kinases named cyclin‐dependent kinases (cdks). Specific cyclin‐cdk complexes are sequentially activated during the cell cycle. Cyclin D‐cdk4 and cyclin E‐cdk2 are activated during the G1 phase, cyclin A‐cdk2 is activated during the S phase, and cyclin B‐cdk1 during mitosis.

Toshiro Niki, Milos Pekny, Karine Hellemans, Pieter De Bleser, Kit Van Den Berg, Freya Vaeyens, Erik Quartier, Frans Schuit, Albert Geerts – 30 December 2003 – Hepatic stellate cells are considered to be liver‐specific pericytes that play a key role in liver fibrosis. Because these cells express desmin and smooth muscle α‐actin, they were assumed to be of myogenic origin. This hypothesis became doubtful when it was reported that stellate cells also express glial fibrillary acidic protein and neural cell adhesion molecule.

30 December 2003

Malek Louha, Jérome Nicolet, Herve Zylberberg, Abdelmajid Sabile, Corinne Vons, Giovanna Vona, Karine Poussin, Monique Tournebize, Frédérique Capron, Stanislas Pol, Dominique Franco, Bernard Lacour, Christian Bréchot, Patrizia Paterlini‐Bréchot – 30 December 2003 – We have investigated whether liver resection and needle liver biopsy cause dissemination of liver cells into peripheral blood circulation, using a reverse‐transcription polymerase chain reaction (RT‐PCR)‐based assay targeted against α‐fetoprotein (AFP) mRNA.

Yasuo Yamaguchi, Kazutoshi Okabe, Fujio Matsumura, Eiji Akizuki, Teishi Matsuda, Hajime Ohshiro, Jian Liang, Shinwa Yamada, Katsutaka Mori, Michio Ogawa – 30 December 2003 – The role of nitric oxide (NO) on tissue injury of hepatic allografts during rejection remains controversial. We investigated inducible nitric oxide synthase (iNOS) expression and formation of peroxynitrite in ACI rat liver grafts implanted in recipients.

David L. Thomas – 30 December 2003

Charles‐Henry Cottart, Louis Do, Marie‐Céline Blanc, Michel Vaubourdolle, Geneviève Descamps, Dominique Durand, François‐Xavier Galen, Jean‐Pierre Clot – 30 December 2003 – The aim of this study was to evaluate the protective or deleterious effects of endogenous nitric oxide (NO) on liver cells during hepatic ischemia‐reperfusion (IR) in the rat. Injury to hepatocytes and endothelial cells was evaluated by determining cytolysis‐marker activity in plasma (alanine transaminase [ALT]; aspartate transaminase [AST]) and plasma hyaluronic acid (HA) concentration.

Marina Baptista, Anna Kramvis, Michael C. Kew – 30 December 2003 – The purpose of this study was to identify mutations in the basic core promoter and enhancer II region of the hepatitis B virus (HBV) that might cause the HBV e antigen (HBeAg)‐negative phenotype and contribute to hepatocarcinogenesis in black African carriers of the virus. The basic core promoter/enhancer II overlaps with the X gene. HBV DNA from serum of 47 asymptomatic carriers and 50 patients with hepatocellular carcinoma and from 28 tumor and 10 nontumor liver tissues was amplified and sequenced directly.